Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis

被引:23
作者
Cadoni, G
Marinelli, L
De Santis, A
Romito, A
Manna, R
Ottaviani, F
机构
[1] Univ Cattolica Sacro Cuore, Inst Otolaryngol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy
关键词
hearing loss; sensorineural; Interferon; alpha; endothelium; antibody formation;
D O I
10.1017/S0022215100142197
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Alpha interferon (alpha-IFN) is used for the treatment of various systemic disorders. Side-effects of alpha-IFN therapy can involve numerous organ systems, but sudden bearing loss has only once been recorded. We report a case of sudden hearing loss occurring in a patient with chronic hepatitis C treated with alpha-IFN and recovered five days after the discontinuation of this agent. This is the first record of anti-endothelial cell antibodies detection in a patient with sudden hearing loss. The finding of anti-endothelial cell antibodies suggests an association between sudden hearing loss and microvascular damage during interferon therapy.
引用
收藏
页码:962 / 963
页数:2
相关论文
共 24 条
[11]   SUDDEN HEARING-LOSS ASSOCIATED WITH INTERFERON [J].
KANDA, Y ;
SHIGENO, K ;
KINOSHITA, N ;
NAKAO, K ;
YANO, M ;
MATSUO, H .
LANCET, 1994, 343 (8906) :1134-1135
[12]   PRELIMINARY-OBSERVATIONS ON THE EFFECT OF RECOMBINANT LEUKOCYTE-A INTERFERON IN HOMOSEXUAL MEN WITH KAPOSIS SARCOMA [J].
KROWN, SE ;
REAL, FX ;
CUNNINGHAMRUNDLES, S ;
KOZINER, B ;
FEIN, S ;
MITTELMAN, A ;
OETTGEN, HF ;
SAFAI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (18) :1071-1076
[13]   DEVELOPMENT OF THYROID-DISEASE DURING THERAPY OF CHRONIC VIRAL-HEPATITIS WITH INTERFERON ALFA [J].
LISKERMELMAN, M ;
DIBISCEGLIE, AM ;
USALA, SJ ;
WEINTRAUB, B ;
MURRAY, LM ;
HOOFNAGLE, JH .
GASTROENTEROLOGY, 1992, 102 (06) :2155-2160
[14]   Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy [J].
Lyons, JL ;
Rosenbaum, JT .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (01) :61-64
[15]   Cytokine-induced autoimmune disorders [J].
Miossec, P .
DRUG SAFETY, 1997, 17 (02) :93-104
[16]   ANTITUMOR-ACTIVITY OF RECOMBINANT-DERIVED INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA [J].
QUESADA, JR ;
RIOS, A ;
SWANSON, D ;
TROWN, P ;
GUTTERMAN, JU .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1522-1528
[17]  
SERTOLI MR, 1989, ONCOLOGY, V46, P96
[18]  
Skalla K, 1996, Semin Oncol Nurs, V12, P97, DOI 10.1016/S0749-2081(96)80004-0
[19]   TYPE-I INTERFERON INHIBITION OF SUPERANTIGEN STIMULATION - IMPLICATIONS FOR TREATMENT OF SUPERANTIGEN-ASSOCIATED DISEASE [J].
SOOS, JM ;
JOHNSON, HM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (01) :39-45
[20]   INTERFERON - IMMUNOBIOLOGY AND CLINICAL-SIGNIFICANCE [J].
STIEHM, ER ;
KRONENBERG, LH ;
ROSENBLATT, HM ;
BRYSON, Y ;
MERIGAN, TC .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (01) :80-93